Clinical trials
Pneumonia clinical trials
Below are recruiting pneumonia clinical trials, each written for real people, not researchers. We’re tracking 261 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07203638Enrolling by invitation
Antibiotics to prevent pneumonia in ventilated patients
This trial tests whether giving preventive antibiotics to adults on breathing machines lowers the risk of developing pneumonia during ventilation. It is a double-blind study, meaning neither you nor your doctor will know if you receive the antibiotic or a placebo.
Banhā, Al-QalyubiaAges 18–70 - NCT07113951Enrolling by invitation
AI-ROSE for diagnosing severe pneumonia
This trial uses an AI tool called AI-ROSE to analyze lung fluid from a bronchoscopy. It aims to help doctors quickly diagnose severe pneumonia and guide treatment.
Nanjing, JiangsuAges 18 years+ - NCT06966817Enrolling by invitation
Mouth care solutions for ventilator patients in the ICU
This study tests two different mouth-care solutions for patients on breathing machines, to see if they can prevent pneumonia and improve mouth health in intensive care.
AnkaraAges 18–90 - NCT06602934Recruiting
Pneumonia, heart health, and your body's germs
This study looks at how pneumonia affects the long-term health of your heart and lungs by studying the germs that live in your body. It may help doctors understand why some people get worse and how to better protect your heart after a serious infection.
AngersAges 18–80 - NCT07453966Recruiting
Lung vibration therapy for people on breathing machines with lung infection
This study tests a device that delivers gentle vibrations to the lungs to help clear infection in people who are on a breathing machine. It may help improve oxygen levels and recovery.
Wuhan, HubeiAges 18 years+ - NCT06495021Recruiting
Osteopathic manipulation for newly diagnosed respiratory illness in older adults
This study tests whether osteopathic manipulation (a gentle hands-on treatment) helps older adults recover from common respiratory illnesses like bronchitis or pneumonia when added to regular care. It may be a good option for you if you're 65 or older and have just been diagnosed with a respiratory infection.
Bloomsburg, PennsylvaniaAges 65–100 - NCT07697885Recruiting
Lefamulin safety and effectiveness in pneumonia
This study watches how well the antibiotic lefamulin works in real-life patients with community-acquired pneumonia. It helps doctors understand the drug's safety and effectiveness outside of a controlled research setting.
Beijing, Beijing MunicipalityAges Any age - NCT07600983RecruitingPhase 1/Phase 2
New pneumococcal vaccine safety and effectiveness study
This trial tests a new vaccine designed to protect against 24 types of pneumococcal bacteria (which cause pneumonia and other serious infections). Researchers are checking if it's safe and how well it works in infants, children, and adults.
ShangqiuAges 1 month+ - NCT06162286RecruitingPhase 3
Comparing two antibiotics for pneumonia in adults
This trial tests a new antibiotic (omadacycline) compared to a standard one (moxifloxacin) for adults with community-acquired pneumonia. The goal is to see if the new drug is as safe and effective.
BeijingAges 18 years+ - NCT04460313Recruiting
Testing bacteria in children’s noses and ears
This study looks at bacteria (especially pneumococcus) in the nose and throat of children. It includes children with ear infections or healthy children, to understand which germs are carried and how they relate to illness.
CréteilAges 6 months–15 years - NCT06881056Recruiting
Aerosol interferon for RSV pneumonia in toddlers
This study tests an inhaled form of peginterferon alpha-2b for children aged 1 to 3 years who have pneumonia caused by RSV. The goal is to see if this treatment helps them recover faster.
Chengdu, SichuanAges 1–3 - NCT07626073Enrolling by invitation
Respiratory Pathogen Testing Methods in ICU Pneumonia
This study compares three different laboratory tests to identify the bacteria or viruses causing pneumonia in ICU patients. The goal is to see which test method helps doctors choose the right antibiotics faster and improves patient outcomes.
TaichungAges 18 years+ - NCT07048275Enrolling by invitation
Virtual reality training for caregivers of children with pneumonia
This trial tests whether a virtual reality (VR) training tool can help caregivers learn chest tapping (percussion) for children with pneumonia, reduce caregiver stress, and improve teaching. If you are a caregiver for a child with pneumonia and meet the health and language requirements, you may be able to join.
YuanlinAges Up to 17 years - NCT07545876Recruiting
Understanding pneumococcal bacteria in Malaysian children
This study collects nasal swabs from young children in Malaysia to learn which types of pneumococcal bacteria are present, which antibiotics work against them, and how they spread. This information helps doctors better treat and prevent pneumococcal infections in children.
Kuala Lumpur, Kuala LumpurAges birth–5 years - NCT05922124RecruitingPhase 4
Testing two antibiotics against resistant lung and bloodstream infections
This trial studies whether cefiderocol plus ampicillin-sulbactam works better than colistin (sometimes with meropenem) for serious infections caused by carbapenem-resistant Acinetobacter baumannii (a hard-to-treat germ). It may help by finding a more effective antibiotic plan for people with these severe hospital-acquired infections.
HaifaAges 16 years+ - NCT07562529Enrolling by invitation
Pneumococcal Bacteria Study in Hospitalized Vietnamese Children
This research study examines how a common bacterium called pneumococcus lives in the noses of young children who are hospitalized with respiratory symptoms. The goal is to understand which types of pneumococcus are present in Vietnam to help improve prevention and treatment strategies.
HanoiAges 2 months–5 years - NCT06029933Recruiting
Comparing two flu vaccines for older adults
This study compares two types of flu shots for people 65 and older to see which works better. If you are a Kaiser Permanente member and get your flu shot at a Kaiser facility, this trial looks at your health records to see how well the vaccine protected you.
Oakland, CaliforniaAges 65 years+ - NCT07744321Recruiting
Bacteria in stool during long ICU stays
This study looks at how certain bacteria (Klebsiella pneumoniae and Enterobacter cloacae) change over time in the stool of ICU patients staying at least 28 days. It aims to understand why these infections occur and how they evolve, which could help improve future care.
CaenAges 18 years+ - NCT07406334RecruitingPhase 1
Pneumococcal booster vaccine study for toddlers
This trial tests a new pneumococcal vaccine as a booster shot in toddlers who already got a full primary series. It aims to see if the booster is safe and produces a strong immune response.
Soweto, Johannesburg, GautengAges 1 year–1.3 years - NCT02979951Recruiting
IV fosfomycin for serious bacterial infections
This trial studies whether IV (through a vein) fosfomycin can treat severe bacterial infections in adults. It may help people whose infection is covered by the standard fosfomycin use and who need hospital-level care.
Hall in TirolAges 18 years+ - NCT03437486Recruiting
Family study for inherited lung scarring causes
This study looks at what causes familial (inherited) pulmonary fibrosis by studying relatives who are not yet diagnosed with the lung disease. You may help researchers understand risk and early changes in the lungs within families.
Nashville, TennesseeAges 40–75 - NCT03482245Recruiting
Study how body clock proteins affect immune responses in infections
This study looks at how your body’s daily “clock” proteins may influence your immune response during certain serious infections requiring hospital care. If you qualify, researchers will compare immune signals during treatment to better understand what could improve care.
St Louis, MissouriAges 18–65 - NCT03478826Recruiting
Donate blood samples for a lung disease research biobank
This study builds a “biobank,” a storage of blood and related samples, from people with lung interstitial lung diseases or other lung scarring diseases. Your samples help researchers study these conditions and improve future care.
Rochester, MinnesotaAges 18 years+ - NCT03748069Recruiting
Study of complications from flu and lung Aspergillus infection
This study looks closely at how influenza (the flu) and a specific kind of lung fungus called Aspergillus affect people who are sick in the ICU with breathing problems. It may help doctors better understand the cause and improve treatment for severe lung infections.
LeuvenAges 18 years+
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pneumonia?
- Yes. Clin2 currently lists 261 recruiting pneumonia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pneumonia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pneumonia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.